STXS

Stereotaxis Inc

$2.29

+0.17 (+8.02%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 20.11.2025
$4.25
(+85.59%)
Strong Buy: 1
Buy: 2
Hold: 0
Sell: 0
Strong Sell: 0
Description:
Stereotaxis, Inc. is a prominent developer of robotic magnetic navigation systems, focusing on revolutionizing treatment methodologies for arrhythmias and coronary artery disease in interventional cardiology. Based in St. Louis, Missouri, the company leverages its proprietary technology to enhance procedural effectiveness and patient safety across hospitals globally. Stereotaxis is dedicated to advancing cardiac care and is actively expanding its market footprint while continually innovating its product lineup, establishing itself as a leader in the rapidly evolving medical device sector.
Exchange:
NYSE MKT
Country:
USA
Sector:
HEALTHCARE
Industry:
MEDICAL INSTRUMENTS & SUPPLIES
Address:
710 NORTH TUCKER BOULEVARD, SAINT LOUIS, MO, UNITED STATES, 63101
Fiscal year end:
December
Market capitalization:
$214 Million
EBITDA:
-$18.9 Million
PERatio:
0.0
EPS:
-0.28
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
1.456

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
+206%
How much will you get:
$3,063
Prices dates:
30-10-2015: $0.95 and 31-10-2025: $2.91